Global EGFR Mutation Test Market Insights, Forecast to 2025

Publisher Name :
Date: 13-Jun-2019
No. of pages: 115
Inquire Before Buying

Epidermal growth factor receptor (EGFR) is a type of protein, which is located on the surface of human body cells. Any mutation in EGFR gene can lead to various types of cancer. EGFR functions as a biomarker for non-small cell lung cancer (NSCLC) and due to the mutation of EGFR gene a person may suffer from cancer or may have a tumor growth. Tumors with genetically altered EGFR gene are referred to as EGFR-mutated tumors. EGFR mutation is generally observed in NSCLCs, especially in adenocarcinoma tumors. According to the International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society, there are around 50% of surgically resected lung adenocarcinomas in EGFR mutations. These mutations are related to micro papillary predominant subtype and the bronchioloalveolar carcinoma. EGFR biomarker is used in diagnosis of patients with NSCLC. Targeted therapy involving tyrosine kinase inhibitors such as gefitinib and erotinib is used in the treatment of patients with NSCLC. EGFR biomarker detects the presence of specific alterations in EGFR gene, which may lead to the development of tumor.   

Increasing global prevalence of lung cancer is expected to fuel growth of the global EGFR mutation test market over the forecast period. Increasing adoption of biomarker therapy is also expected to boost growth of the market worldwide over the forecast period.

The global EGFR Mutation Test market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the EGFR Mutation Test market based on company, product type, end user and key regions.

This report studies the global market size of EGFR Mutation Test in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of EGFR Mutation Test in these regions.

This research report categorizes the global EGFR Mutation Test market by top players/brands, region, type and end user. This report also studies the global EGFR Mutation Test market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Abbott

- Merck

- Thermo Fisher Scientific

- Illumina

- BioMerieux

- QIAGEN

- Agilent Technologies

- Hologic

- Novartis

- Roche

- Genomic Health

Market size by Product

- DNA Sequencing

- Kits

Market size by End User

- Cancer Hospitals

- Clinical Research Institutes

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global EGFR Mutation Test market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of EGFR Mutation Test market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global EGFR Mutation Test companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of EGFR Mutation Test submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of EGFR Mutation Test are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of EGFR Mutation Test market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global EGFR Mutation Test Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 EGFR Mutation Test Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global EGFR Mutation Test Market Size Growth Rate by Product
1.4.2 DNA Sequencing
1.4.3 Kits
1.5 Market by End User
1.5.1 Global EGFR Mutation Test Market Size Growth Rate by End User
1.5.2 Cancer Hospitals
1.5.3 Clinical Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global EGFR Mutation Test Market Size
2.1.1 Global EGFR Mutation Test Revenue 2014-2025
2.1.2 Global EGFR Mutation Test Sales 2014-2025
2.2 EGFR Mutation Test Growth Rate by Regions
2.2.1 Global EGFR Mutation Test Sales by Regions
2.2.2 Global EGFR Mutation Test Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 EGFR Mutation Test Sales by Manufacturers
3.1.1 EGFR Mutation Test Sales by Manufacturers
3.1.2 EGFR Mutation Test Sales Market Share by Manufacturers
3.1.3 Global EGFR Mutation Test Market Concentration Ratio (CR5 and HHI)
3.2 EGFR Mutation Test Revenue by Manufacturers
3.2.1 EGFR Mutation Test Revenue by Manufacturers (2014-2019)
3.2.2 EGFR Mutation Test Revenue Share by Manufacturers (2014-2019)
3.3 EGFR Mutation Test Price by Manufacturers
3.4 EGFR Mutation Test Manufacturing Base Distribution, Product Types
3.4.1 EGFR Mutation Test Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers EGFR Mutation Test Product Type
3.4.3 Date of International Manufacturers Enter into EGFR Mutation Test Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global EGFR Mutation Test Sales by Product
4.2 Global EGFR Mutation Test Revenue by Product
4.3 EGFR Mutation Test Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global EGFR Mutation Test Breakdown Data by End User
6 North America
6.1 North America EGFR Mutation Test by Countries
6.1.1 North America EGFR Mutation Test Sales by Countries
6.1.2 North America EGFR Mutation Test Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America EGFR Mutation Test by Product
6.3 North America EGFR Mutation Test by End User
7 Europe
7.1 Europe EGFR Mutation Test by Countries
7.1.1 Europe EGFR Mutation Test Sales by Countries
7.1.2 Europe EGFR Mutation Test Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe EGFR Mutation Test by Product
7.3 Europe EGFR Mutation Test by End User
8 Asia Pacific
8.1 Asia Pacific EGFR Mutation Test by Countries
8.1.1 Asia Pacific EGFR Mutation Test Sales by Countries
8.1.2 Asia Pacific EGFR Mutation Test Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific EGFR Mutation Test by Product
8.3 Asia Pacific EGFR Mutation Test by End User
9 Central & South America
9.1 Central & South America EGFR Mutation Test by Countries
9.1.1 Central & South America EGFR Mutation Test Sales by Countries
9.1.2 Central & South America EGFR Mutation Test Revenue by Countries
9.1.3 Brazil
9.2 Central & South America EGFR Mutation Test by Product
9.3 Central & South America EGFR Mutation Test by End User
10 Middle East and Africa
10.1 Middle East and Africa EGFR Mutation Test by Countries
10.1.1 Middle East and Africa EGFR Mutation Test Sales by Countries
10.1.2 Middle East and Africa EGFR Mutation Test Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa EGFR Mutation Test by Product
10.3 Middle East and Africa EGFR Mutation Test by End User
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Company Business Overview
11.1.3 Abbott EGFR Mutation Test Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Abbott EGFR Mutation Test Products Offered
11.1.5 Abbott Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Company Business Overview
11.2.3 Merck EGFR Mutation Test Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Merck EGFR Mutation Test Products Offered
11.2.5 Merck Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Company Business Overview
11.3.3 Thermo Fisher Scientific EGFR Mutation Test Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Thermo Fisher Scientific EGFR Mutation Test Products Offered
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Company Business Overview
11.4.3 Illumina EGFR Mutation Test Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Illumina EGFR Mutation Test Products Offered
11.4.5 Illumina Recent Development
11.5 BioMerieux
11.5.1 BioMerieux Company Details
11.5.2 Company Business Overview
11.5.3 BioMerieux EGFR Mutation Test Sales, Revenue and Gross Margin (2014-2019)
11.5.4 BioMerieux EGFR Mutation Test Products Offered
11.5.5 BioMerieux Recent Development
11.6 QIAGEN
11.6.1 QIAGEN Company Details
11.6.2 Company Business Overview
11.6.3 QIAGEN EGFR Mutation Test Sales, Revenue and Gross Margin (2014-2019)
11.6.4 QIAGEN EGFR Mutation Test Products Offered
11.6.5 QIAGEN Recent Development
11.7 Agilent Technologies
11.7.1 Agilent Technologies Company Details
11.7.2 Company Business Overview
11.7.3 Agilent Technologies EGFR Mutation Test Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Agilent Technologies EGFR Mutation Test Products Offered
11.7.5 Agilent Technologies Recent Development
11.8 Hologic
11.8.1 Hologic Company Details
11.8.2 Company Business Overview
11.8.3 Hologic EGFR Mutation Test Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Hologic EGFR Mutation Test Products Offered
11.8.5 Hologic Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Company Business Overview
11.9.3 Novartis EGFR Mutation Test Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Novartis EGFR Mutation Test Products Offered
11.9.5 Novartis Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Company Business Overview
11.10.3 Roche EGFR Mutation Test Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Roche EGFR Mutation Test Products Offered
11.10.5 Roche Recent Development
11.11 Genomic Health
12 Future Forecast
12.1 EGFR Mutation Test Market Forecast by Regions
12.1.1 Global EGFR Mutation Test Sales Forecast by Regions 2019-2025
12.1.2 Global EGFR Mutation Test Revenue Forecast by Regions 2019-2025
12.2 EGFR Mutation Test Market Forecast by Product
12.2.1 Global EGFR Mutation Test Sales Forecast by Product 2019-2025
12.2.2 Global EGFR Mutation Test Revenue Forecast by Product 2019-2025
12.3 EGFR Mutation Test Market Forecast by End User
12.4 North America EGFR Mutation Test Forecast
12.5 Europe EGFR Mutation Test Forecast
12.6 Asia Pacific EGFR Mutation Test Forecast
12.7 Central & South America EGFR Mutation Test Forecast
12.8 Middle East and Africa EGFR Mutation Test Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 EGFR Mutation Test Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure EGFR Mutation Test Product Picture
Table EGFR Mutation Test Market Segments
Table Key Manufacturers EGFR Mutation Test Covered
Table Global EGFR Mutation Test Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global EGFR Mutation Test Sales Market Share by Product 2014-2025
Figure DNA Sequencing Product Picture
Table Major Manufacturers of DNA Sequencing
Figure Kits Product Picture
Table Major Manufacturers of Kits
Table Global EGFR Mutation Test Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Cancer Hospitals
Figure Clinical Research Institutes
Figure EGFR Mutation Test Report Years Considered
Figure Global EGFR Mutation Test Market Size 2014-2025 (Million US$)
Figure Global EGFR Mutation Test Sales 2014-2025 (K Units)
Table Global EGFR Mutation Test Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global EGFR Mutation Test Sales by Regions 2014-2019 (K Units)
Table Global EGFR Mutation Test Sales Market Share by Regions 2014-2019
Figure Global EGFR Mutation Test Sales Market Share by Regions 2014-2019
Figure 2018 Global EGFR Mutation Test Sales Market Share by Regions
Table Global EGFR Mutation Test Revenue by Regions 2014-2019 (Million US$)
Table Global EGFR Mutation Test Revenue Market Share by Regions 2014-2019
Figure Global EGFR Mutation Test Revenue Market Share by Regions 2014-2019
Figure 2018 Global EGFR Mutation Test Revenue Market Share by Regions
Table Global EGFR Mutation Test Sales by Manufacturers (2014-2019) (K Units)
Table Global EGFR Mutation Test Sales Share by Manufacturers (2014-2019)
Figure Global EGFR Mutation Test Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table EGFR Mutation Test Revenue by Manufacturers (2014-2019) (Million USD)
Table EGFR Mutation Test Revenue Share by Manufacturers (2014-2019)
Figure EGFR Mutation Test Value Share by Manufacturers in 2018
Table Key Manufacturers EGFR Mutation Test Price (2014-2019) (USD/Unit)
Table EGFR Mutation Test Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers EGFR Mutation Test Product Type
Table Date of International Manufacturers Enter into EGFR Mutation Test Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global EGFR Mutation Test Sales by Product (2014-2019) (K Units)
Table Global EGFR Mutation Test Sales Share by Product (2014-2019)
Figure Global EGFR Mutation Test Sales Market Share by Product (2014-2019)
Figure Global EGFR Mutation Test Sales Market Share by Product in 2018
Table Global EGFR Mutation Test Revenue by Product (2014-2019) (Million US$)
Table Global EGFR Mutation Test Revenue Share by Product (2014-2019)
Figure Global EGFR Mutation Test Revenue Market Share by Product (2014-2019)
Figure Global EGFR Mutation Test Revenue Market Share by Product in 2018
Table EGFR Mutation Test Price by Product 2014-2019 (USD/Unit)
Table Global EGFR Mutation Test Sales by End User (2014-2019) (K Units)
Table Global EGFR Mutation Test Sales Share by End User (2014-2019)
Figure Global Sales EGFR Mutation Test Market Share by End User (2014-2019)
Figure Global Sales EGFR Mutation Test Market Share by End User in 2018
Figure North America EGFR Mutation Test Sales Growth Rate 2014-2019 (K Units)
Figure North America EGFR Mutation Test Revenue Growth Rate 2014-2019 (Million US$)
Table North America EGFR Mutation Test Sales by Countries (2014-2019) (K Units)
Table North America EGFR Mutation Test Sales Market Share by Countries (2014-2019)
Figure 2018 North America EGFR Mutation Test Sales Market Share by Countries
Table North America EGFR Mutation Test Revenue by Countries (2014-2019) (Million US$)
Table North America EGFR Mutation Test Revenue Market Share by Countries (2014-2019)
Figure 2018 North America EGFR Mutation Test Revenue Market Share by Countries
Figure United States EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure United States EGFR Mutation Test Revenue Growth Rate (2014-2019) (K Units)
Figure Canada EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure Canada EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure Mexico EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Table North America EGFR Mutation Test Sales by Product (2014-2019) (K Units)
Table North America EGFR Mutation Test Sales Market Share by Product (2014-2019)
Figure 2018 North America EGFR Mutation Test Market Share by Product
Table North America EGFR Mutation Test Sales by End User (2014-2019) (K Units)
Table North America EGFR Mutation Test Sales Market Share by End User (2014-2019)
Figure 2018 North America EGFR Mutation Test Market Share by End User
Figure Europe EGFR Mutation Test Sales Growth Rate 2014-2019 (K Units)
Figure Europe EGFR Mutation Test Revenue Growth Rate 2014-2019 (Million US$)
Table Europe EGFR Mutation Test Sales by Countries (2014-2019) (K Units)
Table Europe EGFR Mutation Test Sales Market Share by Countries (2014-2019)
Figure 2018 Europe EGFR Mutation Test Sales Market Share by Countries
Table Europe EGFR Mutation Test Revenue by Countries (2014-2019) (Million US$)
Table Europe EGFR Mutation Test Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe EGFR Mutation Test Revenue Market Share by Countries
Figure Germany EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure Germany EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Figure France EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure France EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Figure UK EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure UK EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure Italy EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure Russia EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Table Europe EGFR Mutation Test Sales by Product (2014-2019) (K Units)
Table Europe EGFR Mutation Test Sales Market Share by Product (2014-2019)
Figure 2018 Europe EGFR Mutation Test Market Share by Product
Table Europe EGFR Mutation Test Sales by End User (2014-2019) (K Units)
Table Europe EGFR Mutation Test Sales Market Share by End User (2014-2019)
Figure 2018 Europe EGFR Mutation Test Market Share by End User
Figure Asia Pacific EGFR Mutation Test Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific EGFR Mutation Test Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific EGFR Mutation Test Sales by Countries (2014-2019) (K Units)
Table Asia Pacific EGFR Mutation Test Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific EGFR Mutation Test Sales Market Share by Countries
Table Asia Pacific EGFR Mutation Test Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific EGFR Mutation Test Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific EGFR Mutation Test Revenue Market Share by Countries
Figure China EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure China EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure Japan EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure Korea EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Figure India EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure India EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure Australia EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure Philippines EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure Thailand EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure Singapore EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific EGFR Mutation Test Sales by Product (2014-2019) (K Units)
Table Asia Pacific EGFR Mutation Test Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific EGFR Mutation Test Market Share by Product
Table Asia Pacific EGFR Mutation Test Sales by End User (2014-2019) (K Units)
Table Asia Pacific EGFR Mutation Test Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific EGFR Mutation Test Market Share by End User
Figure Central & South America EGFR Mutation Test Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America EGFR Mutation Test Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America EGFR Mutation Test Sales by Countries (2014-2019) (K Units)
Table Central & South America EGFR Mutation Test Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America EGFR Mutation Test Sales Market Share by Countries
Table Central & South America EGFR Mutation Test Revenue by Countries (2014-2019) (Million US$)
Table Central & South America EGFR Mutation Test Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America EGFR Mutation Test Revenue Market Share by Countries
Figure Brazil EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure Brazil EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure Argentina EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America EGFR Mutation Test Sales by Product (2014-2019) (K Units)
Table Central & South America EGFR Mutation Test Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America EGFR Mutation Test Market Share by Product
Table Central & South America EGFR Mutation Test Sales by End User (2014-2019) (K Units)
Table Central & South America EGFR Mutation Test Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America EGFR Mutation Test Market Share by End User
Figure Middle East and Africa EGFR Mutation Test Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa EGFR Mutation Test Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa EGFR Mutation Test Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa EGFR Mutation Test Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa EGFR Mutation Test Sales Market Share by Countries
Table Middle East and Africa EGFR Mutation Test Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa EGFR Mutation Test Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa EGFR Mutation Test Revenue Market Share by Countries
Figure GCC Countries EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure Turkey EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure Egypt EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa EGFR Mutation Test Sales Growth Rate (2014-2019) (K Units)
Figure South Africa EGFR Mutation Test Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa EGFR Mutation Test Sales by Product (2014-2019) (K Units)
Table Middle East and Africa EGFR Mutation Test Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa EGFR Mutation Test Market Share by Product
Table Middle East and Africa EGFR Mutation Test Sales by End User (2014-2019) (K Units)
Table Middle East and Africa EGFR Mutation Test Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa EGFR Mutation Test Market Share by End User
Table Abbott Company Details
Table Abbott EGFR Mutation Test Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Recent Development
Table Merck Company Details
Table Merck EGFR Mutation Test Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Thermo Fisher Scientific Company Details
Table Thermo Fisher Scientific EGFR Mutation Test Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Thermo Fisher Scientific Recent Development
Table Illumina Company Details
Table Illumina EGFR Mutation Test Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Illumina Recent Development
Table BioMerieux Company Details
Table BioMerieux EGFR Mutation Test Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table BioMerieux Recent Development
Table QIAGEN Company Details
Table QIAGEN EGFR Mutation Test Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table QIAGEN Recent Development
Table Agilent Technologies Company Details
Table Agilent Technologies EGFR Mutation Test Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Agilent Technologies Recent Development
Table Hologic Company Details
Table Hologic EGFR Mutation Test Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Hologic Recent Development
Table Novartis Company Details
Table Novartis EGFR Mutation Test Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Roche Company Details
Table Roche EGFR Mutation Test Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Recent Development
Table Genomic Health Company Details
Table Global EGFR Mutation Test Sales Forecast by Regions 2019-2025 (K Units)
Table Global EGFR Mutation Test Sales Market Share Forecast by Regions 2019-2025
Table Global EGFR Mutation Test Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global EGFR Mutation Test Revenue Market Share Forecast by Regions 2019-2025
Table Global EGFR Mutation Test Sales Forecast by Product 2019-2025 (K Units)
Table Global EGFR Mutation Test Sales Market Share Forecast by Product 2019-2025
Table Global EGFR Mutation Test Revenue Forecast by Product 2019-2025 (Million US$)
Table Global EGFR Mutation Test Revenue Market Share Forecast by Product 2019-2025
Table Global EGFR Mutation Test Sales Forecast by End User 2019-2025 (K Units)
Table Global EGFR Mutation Test Sales Market Share Forecast by End User 2019-2025
Figure North America EGFR Mutation Test Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America EGFR Mutation Test Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe EGFR Mutation Test Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe EGFR Mutation Test Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific EGFR Mutation Test Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific EGFR Mutation Test Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America EGFR Mutation Test Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America EGFR Mutation Test Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa EGFR Mutation Test Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa EGFR Mutation Test Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table EGFR Mutation Test Value Chain
Table EGFR Mutation Test Customers List
Table EGFR Mutation Test Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs